Safety, Tolerability, and Immunogenicity Study of a 31-Valent Pneumococcal Conjugate Vaccine (VAX-31) in Adults

Clinical trial NCT06151288 · COMPLETED

Trial details

NCT number: NCT06151288
Sponsor: Vaxcyte, Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Pneumococcal Vaccines

Start date: 2023-11-08
Primary completion: 2024-07-17
Enrollment: 1015

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.